1. Home
  2. MURA vs IZM Comparison

MURA vs IZM Comparison

Compare MURA & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • IZM
  • Stock Information
  • Founded
  • MURA 2013
  • IZM 2011
  • Country
  • MURA Ireland
  • IZM China
  • Employees
  • MURA N/A
  • IZM N/A
  • Industry
  • MURA
  • IZM Consumer Electronics/Video Chains
  • Sector
  • MURA
  • IZM Consumer Discretionary
  • Exchange
  • MURA Nasdaq
  • IZM Nasdaq
  • Market Cap
  • MURA 30.7M
  • IZM 31.8M
  • IPO Year
  • MURA N/A
  • IZM 2023
  • Fundamental
  • Price
  • MURA $1.82
  • IZM $2.42
  • Analyst Decision
  • MURA Strong Buy
  • IZM
  • Analyst Count
  • MURA 3
  • IZM 0
  • Target Price
  • MURA $12.00
  • IZM N/A
  • AVG Volume (30 Days)
  • MURA 281.7K
  • IZM 30.2K
  • Earning Date
  • MURA 08-04-2025
  • IZM 08-26-2025
  • Dividend Yield
  • MURA N/A
  • IZM N/A
  • EPS Growth
  • MURA N/A
  • IZM N/A
  • EPS
  • MURA N/A
  • IZM N/A
  • Revenue
  • MURA N/A
  • IZM $180,553,977.00
  • Revenue This Year
  • MURA N/A
  • IZM N/A
  • Revenue Next Year
  • MURA N/A
  • IZM N/A
  • P/E Ratio
  • MURA N/A
  • IZM N/A
  • Revenue Growth
  • MURA N/A
  • IZM N/A
  • 52 Week Low
  • MURA $0.95
  • IZM $1.18
  • 52 Week High
  • MURA $4.74
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • MURA 36.95
  • IZM 38.69
  • Support Level
  • MURA $1.53
  • IZM $2.52
  • Resistance Level
  • MURA $1.83
  • IZM $2.61
  • Average True Range (ATR)
  • MURA 0.17
  • IZM 0.08
  • MACD
  • MURA -0.01
  • IZM -0.01
  • Stochastic Oscillator
  • MURA 33.33
  • IZM 17.09

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: